(Date:1/7/2009)...es in South, Southwest; lowest rates in Northeast,...7 (HealthDay News) -- The teen birth rate in the U...006, representing almost every region of the count...ck in December 2007, the U.S. Centers for Disease ...h rate for the entire nation had increased for the...
(Date:1/7/2009)...ore) The Greenwall Foundation recently awarded tw... Institute of Bioethics a grant that will allow Dr... the ethical challenges health professionals face ... life-threatening neuromuscular diseases (LTNMD). ...ut of the work of the international HeartSongs Pro...
(Date:1/7/2009)... CLAIRE, Wis., Jan. 7 A medical re...t care. Sacred Heart Hospital makes this connectio...surgical suite providing,state-of-the-art treatme..., (Photo: http://www.newscom.com/cgi-bin/prn...advanced imagery and mapping technology, the Smart...
(Date:1/7/2009)...MILLS, Md., Jan. 7 Medif...lled weight-loss program, today announced they,ve ...EO magazine. Medifast is a 2007 and 2009 winner o...izes the 50 fastest growing companies in the Great...owth. Medifast announced on December 16, 2008 that...
Breaking Medicine News(10 mins):Health News:Teen Birth Rate Up in 26 States in 2006 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3Health News:Medifast Named Baltimore SmartCEO Future 50 Company for Second Time 2...ce their weight and stress by undergoing Yoga foll...ce personnel’s in a district in Madhya Pradesh wer...y feared bandit gang operate in parts of Madhya Pr...i which forms part of the Chambal ravines in north...
...sed to predict the risk for a fast and dangerous h...nts whose muscle wall thickness contained over 25 ...ely to likely to test positive according to resear...e findings can be extrapolated to accurately predi...
...t in action or effect of a particular drug than th...e phenomenon could be exploited in the present sce... threat across different regions of the globe. // ...onal flu, because it will be a first line of defen...
...ne, secreted by the ovary and is necessary for nor...d secondary sexual characteristics. It is also req...t research conducted has revealed that the hormone...man. Infact women with high levels of the sex ho...
Other Medicine News:Health News:MRI can predict risk of cardiac arrhythmia by identification of scar tissue, 2Health News:Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid 2(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua H...hua.com ), the worldwide leader in using stem cell...ounced today six new globally experienced addition...ntly expand the hospital,s treatment capabilities ...ents. The six senior doctors include the distingui...
(Date:1/6/2009)..., NEW YORK, Jan. 6 The...t $2.7 million to four industry research teams for... for Parkinson,s disease. , , The funding was a...pment Initiative. This program, first launched in...rts on Parkinson,s research. TDI is part of MJFF...
(Date:1/5/2009)..., SAN DIEGO, Jan. 5 Cylene Pharma...Phase I clinical trial of its oral CK2 protein kin...solid tumors, Castleman,s disease, or multiple mye...ating trial are determination of safety, tolerance...propriate dose for Phase II trials. In addition, m...
(Date:12/29/2008)..., BETHESDA, Md., Dec. 29 /PRNewswire-USNewswire/ ...Human Research Protection was announced today by D...the Health Improvement Institute. , , The winn...xas M.D. Anderson Cancer Center -- for its best..." This program provides for 1) enhanced human sub...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 32008 Human Research Protection Award Recipients Announced 2New Michael J Fox Foundation Initiative Will Drive Development of Web Based Tools to Increase Patient Participation in Parkinsons Clinical Trials 1562 1New Michael J Fox Foundation Initiative Will Drive Development of Web Based Tools to Increase Patient Participation in Parkinsons Clinical Trials 1562 2Columbia University Medical Center NYPH receive 2428 million donation toward curing diabetes 14747 1Columbia University Medical Center NYPH receive 2428 million donation toward curing diabetes 14747 2Columbia University Medical Center NYPH receive 2428 million donation toward curing diabetes 14747 3Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 14745 1Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 14745 2Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 14745 3Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 14745 4Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 14745 5Spartan Stores Becomes Largest U S Supermarket Chain to Receive NSF Shop Fresh 28TM 29 Certification 14743 1Spartan Stores Becomes Largest U S Supermarket Chain to Receive NSF Shop Fresh 28TM 29 Certification 14743 2Spartan Stores Becomes Largest U S Supermarket Chain to Receive NSF Shop Fresh 28TM 29 Certification 14743 3...un 1, 2007 - A therapeutic,vaccine developed by th...mises new hope for cancer patients. The results of...resented to an,international audience at the Annua...Oncology (ASCO) in Chicago, USA. ASCO is the,most ...ialists,world-wide., The active substance VPM4001,...
... 1, 2007 - OXiGENE, Inc.,(NASDAQ: OXGN, XSSE: OXGN...loping novel therapeutics to treat cancer and eye,...bstracts in the,2007 Annual Meeting program distri...American Society of Clinical Oncology (ASCO),in Ch...st time full data from a,randomized Phase II trial...
Other Medicine Technology:Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001 2OXiGENE Abstracts Published in ASCO Program 2OXiGENE Abstracts Published in ASCO Program 3OXiGENE Abstracts Published in ASCO Program 4For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative detection of single and multiple drugs and drug metabolites in human urine
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens
Medicine Products: